MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0267037
Siro Clinpharm Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹40.18 Cr
▲ 13% YoY
Net profit · FY 2025
₹12.26 Cr
Net margin 30.5%
EBITDA · FY 2025
₹16.75 Cr
EBITDA margin 41.7%
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹6.1 Lakh
Issued & subscribed
Open charges
₹5.16 Cr
Satisfied ₹119.93 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
258
Provident fund records
About Siro Clinpharm Private Limited
Data last updated:
Siro Clinpharm Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 March 2000 and has been in existence for over 26 years.
Its director Gautam Daftary and family are #1,009 on the Hurun India Rich List 2026.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2000PTC125061. Its GSTIN is 27AAECS8588A1Z3 (Maharashtra). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹6.1 Lakh. It is led by directors including Karan Gautam Daftary (Whole-Time Director) and Akshay Gautam Daftary.
Its last annual general meeting (AGM) was held on 31 December 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 16th Floor Hoechst House Nariman Point Mumbai, Mumbai City Mh 400021, Maharashtra, India – 400021.
As per the financials filed for FY 2025, the company reported a revenue of ₹40.18 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹12.26 Cr (net margin 30.5%) and EBITDA of ₹16.75 Cr (EBITDA margin 41.7%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years and 8% over five years.
The company has about 258 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Siro Clinpharm. As per MCA filings, the company has open charges of ₹5.16 Cr and satisfied charges of ₹119.93 Cr on record. Court records list 13 cases involving the company, including 1 filed by the company and 12 filed against it; 2 cases are pending. The company has 12 deals on record (9 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹22.5 Cr; the latest was in February 2022. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Alas Pharmaceuticals Private Limited with revenue of ₹40.4 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2020, listing 1 overdue payment to 1 micro and small supplier.
Siro Clinpharm Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0267037). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website siroclinpharm.com.
Company Details of Siro Clinpharm Private Limited
CIN U24230MH2000PTC125061
Registration Number 125061
Incorporation Date 21 March 2000
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 December 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0267037
Key People
Karan Gautam Daftary Whole-Time Director Akshay Gautam Daftary Director Gautam Vinod Daftary Director Recognitions & Rankings of Siro Clinpharm
Hurun India Rich List 2026 edition · 1 director
- #1,009 Gautam Daftary & family ₹2,700 Cr
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address16th Floor Hoechst House Nariman Point Mumbai, Mumbai City Mh 400021, Maharashtra, India – 400021
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Siro Clinpharm Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Siro Clinpharm Private Limited
Siro Clinpharm operates one associated brand: Siro Clinpharm. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Clinical development services are offered to the global healthcare industry. | siroclinpharm.com |
Financials of Siro Clinpharm Private Limited FY 2024 filings available
Siro Clinpharm Private Limited reported revenue of ₹40.18 Cr (up 13% YoY) for FY 2025.
Revenue · FY 2025
₹40.18 Cr ▲ 13%
Net profit · FY 2025
₹12.26 Cr margin 30.5%
EBITDA · FY 2025
₹16.75 Cr margin 41.7%
Compounded Annual Growth Rate (CAGR) of Siro Clinpharm Private Limited
Revenue CAGR growth
1 year
▲ 13%
3 years · compounded
▼ 16%
5 years · compounded
▼ 8%
EBITDA CAGR growth
1 year
▼ 48%
3 years · compounded
▼ 5%
5 years · compounded
▲ 18%
Revenue rose 13% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 8%. EBITDA fell 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Siro Clinpharm Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹16.75 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹12.26 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Siro Clinpharm Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 41.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 30.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Siro Clinpharm are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Siro Clinpharm Private Limited
Siro Clinpharm has 3 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akshay Gautam Daftary Also directs: Iravata Retail Enterprises LLP, Palettier Retail Private Limited, Aksitech Life Sciences Private Limited and 5 more | Director | 12 Feb 2018 | 8 Years 8 Months | Current |
| Karan Gautam Daftary Also directs: Iravata Retail Enterprises LLP, Ceresity Technologies Private Limited, Siro Medical Writing Private Limited and 5 more | Whole-Time Director | 12 Sep 2018 | 8 Years 1 Months | Current |
| Gautam Vinod Daftary Also directs: Iravata Retail Enterprises LLP, Palettier Retail Private Limited, Hitech Laboratories Private Limited and 5 more | Director | 21 Mar 2000 | 26 Years 6 Months | Current |
Peer Comparison of Siro Clinpharm Private Limited
Siro Clinpharm Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alas Pharmaceuticals Private Limited | ₹40.4 Cr (FY 2021) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Accure Labs Private Limited | ₹40.39 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | New Delhi, Delhi, India |
| Yacca Pharmaceuticals Private Limited | ₹40.38 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Uttar Pradesh, India |
| Vindas Chemical Industries Private Limited | ₹40.36 Cr (FY 2025) | •••• | •••• | 74.0% | •••• | Dhar, Madhya Pradesh, India |
| Alkimia Pharma-Chem Private Limited | ₹40.2 Cr (FY 2025) | •••• | •••• | 975.0% | •••• | Hyderabad, Telangana, India |
| Siro Clinpharm Private Limited this company | ₹40.18 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Mumbai, Maharashtra, India |
| Renova Lifesciences Private Limited | ₹40.16 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Rajkot, Gujarat, India |
| Integrated Laboratories Private Limited | ₹40.11 Cr (FY 2024) | •••• | •••• | 24.0% | •••• | Sirmour, Himachal Pradesh, India |
| Vip Pharmaceuticals Private Limited | ₹40.07 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | New Delhi, Delhi, India |
| Meditab Specialities Limited | ₹40.03 Cr (FY 2025) | •••• | •••• | -90.0% | •••• | Mumbai, Maharashtra, India |
| Stellar Formulations Industries Private Limited | ₹39.96 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Vadodara, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Siro Clinpharm by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Siro Clinpharm Private Limited
Siro Clinpharm Private Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Deloitte Haskins & Sells LLP | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Siro Clinpharm Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Siro Clinpharm Private Limited
Open charges
₹5.16 Cr
Satisfied charges
₹119.93 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2024 | Others | ₹1.5 Cr | Open |
| 16 Oct 2024 | Others | ₹1.29 Cr | Open |
| 27 Mar 2024 | Others | ₹1.37 Cr | Open |
| 24 Nov 2021 | Others | ₹1 Cr | Open |
| 12 Mar 2019 | Others | ₹4.5 Cr | Satisfied |
Total charge records: 17 View all charges
Deals & Funding of Siro Clinpharm Private Limited
Siro Clinpharm Private Limited has 12 deals on record (9 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹22.5 Cr; the latest was in February 2022.
Total deals
12
Secondary share transfers
9
Funding rounds
2
Rights issue
1
Disclosed funding
₹22.5 Cr
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
| Sep 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: KOTAK SECURITIES LIMITED |
| Sep 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Kotak Private Equity, 3 individuals |
| Sep 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Jan 2014 | Rights issue | ₹10,000 | Investors: 2 individuals |
Premium access
Full deal history
All 12 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Siro Clinpharm Private Limited
Siro Clinpharm Private Limited has 13 court cases on record: 1 filed by Siro Clinpharm, 12 filed against it. 2 cases are pending and 11 are disposed. Status as checked between 01 Oct 2026 and 04 Oct 2026.
Total cases
13
Filed by the company
1
Filed against the company
12
Pending
2
Disposed
11
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 11 | 11 | 2 |
| District courts | 2 | 1 | 0 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Tax appeal | Filed against the company by PR. Commissioner of Income Tax-3 | Pending |
| Bombay High Court | Tax appeal | Filed against the company by PR. Commissioner of Income Tax- 3 Mumbai | Pending |
| Bombay High Court | Court case (CHOL) | Filed against the company by Commissioner of Service Tax Mumbai VIII Commissionerate | Disposed |
| Bombay High Court | Tax appeal | Filed against the company by Commissioner of Service Tax Mumbai VIII Commissionerate | Disposed |
| Bombay High Court | Court case (NMA) | Filed against the company by Commissioner of Income Tax-3, Mumbai | Disposed |
Premium access
Full case history
All 13 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Siro Clinpharm Private Limited
Siro Clinpharm Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2020, listing 1 overdue payment to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sevenstar Facility India Private Limited | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Siro Clinpharm Private Limited
Siro Clinpharm Private Limited has a workforce of 258 employees as of Mar 22, 2024.
Employee count
258
Active EPFO establishments
1
Employee growth
-1.53%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Siro Clinpharm Private Limited
Siro Clinpharm Private Limited has 18 board changes on record since 2000: 3 appointments and 15 cessations. The latest: Akshay Gautam Daftary ceased to be Additional Director on 30 Jul 2022.
AGM
Siro Clinpharm Private Limited last Annual general meeting of members was held on 31 Dec 2024 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 101035220 was registered on 30 Dec 2024.
Charges
A charge with Others amounted to Rs. 1.29 Cr with Charge ID 100995543 was registered on 16 Oct 2024.
Filing
Siro Clinpharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 1.37 Cr with Charge ID 100910202 was registered on 27 Mar 2024.
Ceased
Akshay Gautam Daftary ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100517853 was registered on 24 Nov 2021.
Charges
A charge registered on 26 Oct 2017 via Charge ID 100159408 with Others was fully satisfied on 08 Nov 2021.
Charges
A charge registered on 12 Mar 2019 via Charge ID 100247782 with Others was fully satisfied on 18 May 2021.
Charges
A charge registered on 12 Mar 2019 via Charge ID 100247781 with Others was fully satisfied on 16 Apr 2021.
Charges
A charge registered on 29 Jan 2014 via Charge ID 10475628 with Others was fully satisfied on 28 Mar 2019.
Charges
A charge with Others amounted to Rs. 4.50 Cr with Charge ID 100247781 was registered on 12 Mar 2019.
42 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Siro Clinpharm Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Siro Clinpharm Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Siro Clinpharm Private Limited
Siro Clinpharm has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECS8588A1Z3 | Maharashtra | Active | 01 Jul 2017 |
| 36AAECS8588A1Z4 | Telangana | Active | 28 Jul 2018 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Siro Clinpharm Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Siro Clinpharm Private Limited
Frequently Asked Questions about Siro Clinpharm Private Limited
Siro Clinpharm is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 March 2000 (26+ years old) and is registered under CIN U24230MH2000PTC125061.
Siro Clinpharm reported revenue of ₹40.18 Cr for FY 2025 (up 13% YoY).
Siro Clinpharm has 3 current directors:
- Karan Gautam Daftary - Whole-Time Director
- Akshay Gautam Daftary - Director
- Gautam Vinod Daftary - Director
Siro Clinpharm reported a net profit of ₹12.26 Cr (net margin 30.5%) and EBITDA of ₹16.75 Cr (EBITDA margin 41.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Siro Clinpharm is -16% over three years and -8% over five years. In the latest year (FY 2025) revenue rose 13%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Siro Clinpharm is 27AAECS8588A1Z3, registered in Maharashtra. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 36AAECS8588A1Z4 (Telangana).
The CIN (Corporate Identification Number) of Siro Clinpharm is U24230MH2000PTC125061. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Siro Clinpharm has 13 court cases on record: 1 filed by the company and 12 filed against it. 2 are pending. Most are in the high courts.
Siro Clinpharm was incorporated on 21 March 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.
Siro Clinpharm has 12 deals on record (9 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹22.5 Cr; the latest was in February 2022.
The peers of Siro Clinpharm by revenue are Alas Pharmaceuticals Private Limited, Accure Labs Private Limited, Yacca Pharmaceuticals Private Limited, Vindas Chemical Industries Private Limited, Alkimia Pharma-Chem Private Limited and 5 more, all in the Pharma industry (Formulations).
Akshay Gautam Daftary ceased to be Additional Director on 30 Jul 2022. Sanjay Chandrasen Rane ceased to be Company Secretary on 31 Jan 2019. Karan Gautam Daftary was appointed as Whole-Time Director on 12 Sep 2018. Siro Clinpharm has 18 board changes on record in total.